ACM
HRMY icon

Aster Capital Management’s Harmony Biosciences HRMY Stock Holding History

Aster Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.48K Buy
+105
New +$3.44K ﹤0.01% 712
2025
Q3 		– Sell
-152
Closed -$4.8K – 1143
2025
Q2 		$4.8K Buy
+152
New +$4.89K ﹤0.01% 871
2025
Q1 		– Sell
-557
Closed -$19.2K – 1439
2024
Q4 		$19.2K Buy
+557
New +$19.1K 0.01% 642

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Aster Capital Management's HRMY Position: Q1 2026 in Review

Aster Capital Management opened a new position in Harmony Biosciences (HRMY) in Q1 2026: 105 shares worth $3.48K. The stake represents ﹤0.01% of the portfolio and ranks #712 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in HRMY as recently as Q2 2025.

Aster Capital Management first reported a position in HRMY in Q4 2024 and has held it in 3 quarters since. The position peaked at $19.2K in Q4 2024. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Aster Capital Management held 105 shares of Harmony Biosciences worth $3.48K as of Q1 2026.
  • Harmony Biosciences was a new Aster Capital Management position in Q1 2026.
  • Harmony Biosciences made up ﹤0.01% of Aster Capital Management's portfolio in Q1 2026, its #712 holding.
  • Aster Capital Management first reported a position in Harmony Biosciences in Q4 2024 and has held it in 3 quarters since.
  • Aster Capital Management's Harmony Biosciences position peaked at $19.2K in Q4 2024.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.